ATE89005T1 - Rekombinantes vektorsystem fuer metalloproteinase- inhibitorsequenz und dessen verwendung und herstellung nach dem rekombinant-dns-verfahren. - Google Patents

Rekombinantes vektorsystem fuer metalloproteinase- inhibitorsequenz und dessen verwendung und herstellung nach dem rekombinant-dns-verfahren.

Info

Publication number
ATE89005T1
ATE89005T1 AT86902087T AT86902087T ATE89005T1 AT E89005 T1 ATE89005 T1 AT E89005T1 AT 86902087 T AT86902087 T AT 86902087T AT 86902087 T AT86902087 T AT 86902087T AT E89005 T1 ATE89005 T1 AT E89005T1
Authority
AT
Austria
Prior art keywords
production
recombinant
metalloproteinase inhibitor
vector system
dna method
Prior art date
Application number
AT86902087T
Other languages
English (en)
Inventor
David F Carmichael
David C Anderson
Floor
George P Stricklin
Howard G Welgus
Original Assignee
Synergen Biolog Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synergen Biolog Inc filed Critical Synergen Biolog Inc
Application granted granted Critical
Publication of ATE89005T1 publication Critical patent/ATE89005T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P15/00—Preparation of compounds containing at least three condensed carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT86902087T 1985-02-05 1986-02-05 Rekombinantes vektorsystem fuer metalloproteinase- inhibitorsequenz und dessen verwendung und herstellung nach dem rekombinant-dns-verfahren. ATE89005T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US69918185A 1985-02-05 1985-02-05
US78431985A 1985-10-04 1985-10-04
PCT/US1986/000302 WO1986004608A1 (en) 1985-02-05 1986-02-05 Metalloproteinase inhibitor sequence recombinant vector system for using same and recombinant-dna method for the manufacture of same
EP86902087A EP0211077B1 (de) 1985-02-05 1986-02-05 Rekombinantes vektorsystem für metalloproteinase-inhibitorsequenz und dessen verwendung und herstellung nach dem rekombinant-dns-verfahren

Publications (1)

Publication Number Publication Date
ATE89005T1 true ATE89005T1 (de) 1993-05-15

Family

ID=27106361

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86902087T ATE89005T1 (de) 1985-02-05 1986-02-05 Rekombinantes vektorsystem fuer metalloproteinase- inhibitorsequenz und dessen verwendung und herstellung nach dem rekombinant-dns-verfahren.

Country Status (9)

Country Link
US (3) US6090585A (de)
EP (1) EP0211077B1 (de)
JP (1) JPH088870B2 (de)
KR (1) KR940010862B1 (de)
AT (1) ATE89005T1 (de)
AU (2) AU5549386A (de)
DE (1) DE3688383T2 (de)
DK (1) DK175964B1 (de)
WO (1) WO1986004608A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0198014A4 (de) * 1984-10-01 1987-11-23 Sandoz Ltd Ein gen für ein protein mit erythroid erhöhender wirkung enthaltende vektoren und rekombinante dns-verfahren zu deren herstellung.
EP0188312A3 (de) * 1985-01-07 1988-01-13 Celltech Limited Verfahren zur Herstellung eines Proteins
JPH01213232A (ja) * 1988-02-22 1989-08-28 Fuji Yakuhin Kogyo Kk 新規な皮膚潰瘍治療剤
AU648505B2 (en) * 1989-05-19 1994-04-28 Amgen, Inc. Metalloproteinase inhibitor
US5714465A (en) 1989-05-19 1998-02-03 Amgen Inc. Method of inhibiting tumor cell dissemination with a metalloproteinase inhibitor
ATE403714T1 (de) 1996-11-06 2008-08-15 Univ California Tumor necrosis factor rezeptor abspaltendes enzym,dessen zubereitungen und verwendungen
AU2002326070A1 (en) * 2001-07-02 2003-01-21 Elan Corporation, Plc Peyers's patch and/or m-celle targeting ligands
JP2010502425A (ja) * 2006-08-30 2010-01-28 ジーイー・ヘルスケア・バイオサイエンス・コーポレイション 膜を評価するシステム及び方法並びに膜濾過装置
US8189753B1 (en) 2007-04-12 2012-05-29 Russound/Fmp Incorporated Distributed intercom system with audio bus

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276284A (en) * 1971-07-26 1981-06-30 Brown Stuart I Prevention of collagenase induced disease by treatment with collagenase inhibitors
US4530901A (en) * 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
ZA814375B (en) * 1980-07-01 1982-07-28 Hoffmann La Roche Interferons and process for their preparation
US4394443A (en) * 1980-12-18 1983-07-19 Yale University Method for cloning genes
US4438032A (en) * 1981-01-30 1984-03-20 The Regents Of The University Of California Unique T-lymphocyte line and products derived therefrom
US4382081A (en) * 1981-06-12 1983-05-03 E. R. Squibb & Sons, Inc. Inhibitors of mammalian collagenase
US4361574A (en) * 1981-10-02 1982-11-30 American Home Products Corporation Inhibitors of mammalian collagenase
AU577259B2 (en) * 1982-08-13 1988-09-22 Zymogenetics Inc. Glycolytic promters for regulated protein expression protease inhibitor
US4512922A (en) * 1982-12-22 1985-04-23 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
GR79124B (de) * 1982-12-22 1984-10-02 Genentech Inc
DE122080T1 (de) * 1983-03-25 1985-05-23 Celltech Ltd., Slough, Berkshire Verfahren zur herstellung eines proteins.
US4609667A (en) * 1983-12-19 1986-09-02 American Home Products Corporation Inhibitor of mammalian collagenase and elastase
US4602006A (en) * 1984-05-09 1986-07-22 Syntex (U.S.A.) Inc. Ynenolactone protease inhibitors
EP0198014A4 (de) * 1984-10-01 1987-11-23 Sandoz Ltd Ein gen für ein protein mit erythroid erhöhender wirkung enthaltende vektoren und rekombinante dns-verfahren zu deren herstellung.
EP0188312A3 (de) * 1985-01-07 1988-01-13 Celltech Limited Verfahren zur Herstellung eines Proteins
GB8500341D0 (en) * 1985-01-07 1985-02-13 Celltech Ltd Production of protein
EP0189784B1 (de) * 1985-01-18 1989-11-08 G.D. Searle & Co. Menschlicher, natürlicher Collagenaseninhibitor
US4897444A (en) * 1985-05-31 1990-01-30 The Research Foundation Of The State University Of New York Immobilized fluorogenic substrates for enzymes; and processes for their preparation

Also Published As

Publication number Publication date
AU636370B2 (en) 1993-04-29
AU5971090A (en) 1990-11-01
DE3688383T2 (de) 1993-08-26
DK422786D0 (da) 1986-09-04
US6090585A (en) 2000-07-18
KR870700096A (ko) 1987-02-28
EP0211077A4 (de) 1987-11-23
JPS62502101A (ja) 1987-08-20
US20030003556A1 (en) 2003-01-02
DE3688383D1 (de) 1993-06-09
AU5549386A (en) 1986-08-26
JPH088870B2 (ja) 1996-01-31
US6342374B1 (en) 2002-01-29
WO1986004608A1 (en) 1986-08-14
EP0211077B1 (de) 1993-05-05
DK422786A (da) 1986-12-05
US6800732B2 (en) 2004-10-05
DK175964B1 (da) 2005-09-26
KR940010862B1 (ko) 1994-11-18
EP0211077A1 (de) 1987-02-25

Similar Documents

Publication Publication Date Title
ATE440863T1 (de) Chemokine peptide, varianten, derivate und analoge. ihre verwendung in methode für die hemmung oder erhíhung von einer entzündungsreaktion
AU8635391A (en) Nucleotide sequences coding for a human protein with angiogenesis regulative properties
ES2000852A6 (es) Un nuevo procedimiento para preparar intermediarios con residuos de acido 5-amino-2,5-disustituido -4- hidroxipentanoico,utiles en la sintesis de polipeptidos inhibidores de renina.
MX9702212A (es) Proteinas plaguicidas novedosas y cepas.
MX9703564A (es) Inhibidores de proteasa multicatalitica.
ZA975443B (en) Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides.
ES8401015A1 (es) Un metodo de preparacion de un peptido.
EP0702694A4 (de) $i(PSEUDOMONAS SYRINGAE) pv. $i(SYRINGAE hrpY)-GEN
ATE89005T1 (de) Rekombinantes vektorsystem fuer metalloproteinase- inhibitorsequenz und dessen verwendung und herstellung nach dem rekombinant-dns-verfahren.
IL106894A0 (en) Dorsal tissue affecting factor and compositions
ES2002053A6 (es) Procedimiento para la obtencion de peptidos inihiobidores de renina que contienen grupos hidroxi.
EP0270234A3 (de) Renin-Inhibitoren
DE69726652T2 (de) Verbesserte Riboflavin-Herstellung
ES2152313T3 (es) Gen grb-3-3, sus variantes y sus utilizaciones.
DE69332514T2 (de) Transformation von Phaffia Rhodozyma
ATE41773T1 (de) 4,5-dihydro-4-oxo-2((2-transphenylcyclopropyl)amino>-3-furancarbonsaeuren und derivate davon.
TR199800871T2 (xx) Bifenil eter-oksazolinler.
AU591892B2 (en) Peptides
DK0652964T3 (da) Promotor af K. lactis transaldolasegenet og anvendelse heraf
ATE46537T1 (de) Promotor und dessen verwendung.
IL119700A0 (en) N-5-protected 2,5-diamino-4,6-dihydroxy-pyrimidines
DE69637429D1 (de) Gene, die für lymphocyte spezifischen interferon-regulationsfaktor (lsirf) polypeptide kodiert
DE69434072D1 (de) Regulierende nukleinsaeuresequenzen und verwendungen
DE3563752D1 (en) Compounds having hypolipemizing activity
AU7291696A (en) Retroviral vectors carrying senescent cell derived inhibitors 1 (sdi-1) or antisense sdi-1 nucleotide sequences

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time